Table 3.
WT | KO | |
---|---|---|
Total Pα positive cells | 178.23 ± 20.3 | 127.94 ± 18.4* |
Pα/BrdU positive cells | 26.4 ± 2.2 | 10.76 ± 2.9 |
Mitotic indices | 14.81 ± 3.1% | 8.41 ± 0.6%** |
Total Pβ positive cells | 29.8 ± 5.7 | 21.91 ± 3.4* |
Pβ/BrdU positive cells | 4.53 ± 0.8 | 2.31 ± 0.9 |
Mitotic indices | 15.2 ± 0.6% | 10.52 ± 0.6%*** |
Total IBA-1 positive cells | 217.94 ± 14.8 | 74.45 ± 12.3*** |
IBA1/BrdU positive cells | 19.66 ± 3.6 | 4.71 ± 3.5 |
Mitotic indices | 9.02 ± 1.2% | 6.32 ± 1.8%* |
Total numbers of PDGFRα (Pα), PDGFRβ (Pβ), and IBA-1 positive cells, along with BrdU incorporation, were determined in 0.1 mm2 areas of the dorsal column at 7 days postsurgery. Mitotic labeling indices for OPCs, pericytes, and macrophages/microglial cells are expressed as the percentage of each cell type that is BrdU positive. Data represent the mean ± S.D. Statistically significant differences between wild type and NG2 null mice are indicated by * < 0.05; ** < 0.01; *** < 0.001.